Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1981 Dec 1;154(6):1838-51.
doi: 10.1084/jem.154.6.1838.

Analysis of T cell hybridomas. II. Comparisons among three distinct types of monoclonal suppressor factors

Comparative Study

Analysis of T cell hybridomas. II. Comparisons among three distinct types of monoclonal suppressor factors

K Okuda et al. J Exp Med. .

Abstract

Five hybridoma T cell lines were prepared by fusion of Ts3 cells with the BW 5147 thymoma. The culture supernatants from these T cell hybrids contained a factor, TsF3, which specifically suppressed 4-hydroxy-3-nitrophenyl acetyl hapten (NP(-hapten cutaneous sensitivity responses. The properties of this new series of hybridoma factors was compared with those of two previously characterized types of NP-specific suppressor factors (TsF1 and TsF2). TsF3 activity was only observed if the factor was administered during the effector phases of the immune response. TsF3 bears I-J and C57BL anti-NP antibody idiotypic determinants and has binding specificity for the NP hapten. Furthermore, TsF3 does not suppress H-2 (I-J)-incompatible mice. In addition to this H-2 restriction, the monoclonal TsF3 factors also demonstrated an Igh genetic restriction. Finally, the TsF3 factors could be distinguished by their ability to suppress cyclophosphamide-treated recipients.

PubMed Disclaimer

References

    1. Transplant Rev. 1975;26:21-38 - PubMed
    1. J Exp Med. 1981 Aug 1;154(2):468-79 - PubMed
    1. Nature. 1978 Aug 3;274(5670):477-80 - PubMed
    1. J Immunol. 1978 Sep;121(3):1034-9 - PubMed
    1. J Exp Med. 1978 Aug 1;148(2):373-82 - PubMed

Publication types